RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India
Moscow, March 22, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), one of the leading vaccine and pharmaceutical producers in India, announce the agreement to produce in the country up to 200 million doses per year of Sputnik V, the world’s first …
RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India Read More »